Jeff Yass’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Jeff Yass’s Portfolio RCPI Stock Details RCPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-131,927	Closed	-$147K	–	10955
2015 Q2	$201K	Buy	131,927 +122,840	+1,352%	+$293K	﹤0.01%	9288
2015 Q1	$23K	Sell	9,087 -25,181	-73%	-$99.1K	﹤0.01%	9265
2014 Q4	$156K	Buy	34,268 +14,150	+70%	+$74.4K	﹤0.01%	8993
2014 Q3	$141K	Sell	20,118 -17,368	-46%	-$172K	﹤0.01%	8935
2014 Q2	$552K	Buy	+37,486	New	+$651K	﹤0.01%	7280

Other funds holding RCPI

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

KCM

Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return

WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return

IWMPD

Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 13.41% 1-Year Est. Return

Jeff Yass's RCPI Position: Q3 2015 in Review

Jeff Yass sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q3 2015, closing a stake of 131,927 shares — an estimated $147K sold.

Jeff Yass first reported a position in RCPI in Q2 2014 and held it in 5 quarters. The position peaked at $552K in Q2 2014. 37 funds tracked by Wall St. Rank hold RCPI as of Q3 2015.

Jeff Yass reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q3 2015 after selling out during the quarter.
Jeff Yass sold 131,927 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q3 2015, an estimated $147K.
Jeff Yass first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 5 quarters.
Jeff Yass's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $552K in Q2 2014.
37 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q3 2015.

Based on Susquehanna International Group's 13F filing for Q3 2015, filed 16 Nov 2015.